CSF3 and neoplasm: IL-6 is a promoter of G-CSF, is associated with tumor progression, and is thought to influence anti-tumor immunity through various mechanisms (Jones and Jenkins 2018; Karagiannidis et al. 2021; Liu et al. 2020).